New biomarker identified for predicting adverse events of tuberculosis therapy
Borstel researchers are the first to develop a biomarker to predict the occurrence of neuropathic adverse events during therapy for multidrug-resistant tuberculosis. The results have now been published in the journal Pathogens ...
Jul 2, 2024
0
0